March 2

Category: 

Food & Beverage Recalls

El Abuelito Expands Recall to Include Queso Fresco, Quesillo, and Requeson Products Because of Possible Health Risk

El Abuelito Cheese of Paterson, NJ is recalling all Queso Fresco (Fresh, soft cheese), Quesillo (Oaxaca, string cheese), and Requeson (Ricotta) products, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria monocytogenes infection can cause miscarriages and stillbirths among pregnant women.

All Queso Fresco products with sell by dates through 032821; all Quesillo (Oaxaca, string cheese) products with sell by dates through 041621; and all Requeson (Ricotta) products with sell by dates through 031421 have been recalled. The products are sold as El Abuelito Cheese brand, distributed in CT, NJ, PA, NY; Rio Grande Food Products brand, distributed in VA, NC, MD; Rio Lindo distributed in NC and MD and Viejito, El Paisano, El Sabrosito, La Cima, Quesos Finos, San Carlos, and Ideal Brands.

The products were distributed through Feb 16, 2021 and were available in supermarkets, wholesale, and retails stores.

J&J Distributing Recalls Multiple Products Because of Possible Health Risk

J&J Distributing of St. Paul, MN, is recalling multiple products because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.

El Abuelito Retira Del Mercado Productos de Queso Fresco por Posible Riesgo a la Salud

El Abuelito Cheese de Paterson, NJ, está retirando del mercado todos los productos de queso fresco (queso fresco, suave), porque pueden estar potencialmente contaminados con Listeria monocytogenes, un organismo que puede causar infecciones graves y, a veces, fatales en niños pequeños, personas frágiles o de mayor edad. Y a personas con sistemas inmunológicos debilitados. Aunque las personas sanas pueden sufrir sólo síntomas a corto plazo como fiebre alta, dolor de cabeza intenso, rigidez, náuseas, dolor abdominal y diarrea, la infección por Listeria monocytogenes puede provocar abortos espontáneos y mortinatos en las mujeres embarazadas.

Todos los productos de queso fresco con fechas de vencimiento hasta 28 de marzo de 2021 (03/28/21) han sido retirados del mercado. Los productos se comercializan bajo la marca El Abuelito Cheese, distribuidos en CT, NJ, PA, NY; la marca Río Grande Food Products, distribuidos en VA, NC, MD; y Río Lindo distribuidos en NC y MD. Los productos fueron distribuidos hasta el 16 de febrero de 2021 y estuvieron disponibles en supermercados, tiendas mayoristas y minoristas.

Medical Devices Recalls

Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System

Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.

In accordance with its commitment to patient safety – and in consultation with independent physicians – Medtronic initiated this action in response to information recently obtained from the Valiant Evo Global Clinical Trial indicating that three patients in the Valiant Evo Global Clinical Trial were observed to have stent fractures, two of which have confirmed type IIIb endoleaks. One patient death was reported.

Following these observations, an independent imaging laboratory reviewed all available images from patients enrolled in the Valiant Evo Global Clinical Trial. Upon further analysis of the images, seven (7) out of 87 patients were observed to have stent ring enlargement beyond the design specification. Those observations require further assessment to determine potential clinical importance.